LivaNova SG&A Expenses 2010-2025 | LIVN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

LivaNova sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

LivaNova sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$180.2B
Intuitive Surgical (ISRG)	$179.4B
Edwards Lifesciences (EW)	$47.6B
IDEXX Laboratories (IDXX)	$46B
Alcon (ALC)	$44B
DexCom (DXCM)	$34.9B
IQVIA Holdings (IQV)	$32.6B
Mettler-Toledo (MTD)	$26.3B
STERIS (STE)	$22.6B
Waters (WAT)	$17.8B
SONOVA HOLDING (SONVY)	$16.4B
Hologic (HOLX)	$14.5B
Sysmex ADR (SSMXY)	$10.4B
Penumbra (PEN)	$9.8B
Masimo (MASI)	$8.5B
Globus Medical (GMED)	$7.2B
Glaukos (GKOS)	$5.4B
Teleflex (TFX)	$5B
Integer Holdings (ITGR)	$3.8B
TransMedics (TMDX)	$3.6B
PROCEPT BioRobotics (PRCT)	$2.8B
Nihon Kohden (NHNKY)	$2B
Elekta AB (EKTAY)	$1.9B
Veracyte (VCYT)	$1.9B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Tandem Diabetes Care (TNDM)	$1.1B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Pulse Biosciences (PLSE)	$991M